CXCR4 and cancer: Additionally, Gao et al. designed a cerium oxide nanoparticle (nanoceria) drug delivery system sensitive to extracellular acidic pH conditions that contained a CXCR4 antagonist and doxorubicin; which enriched targeting to cancer cells and released the chemotherapeutic drug intracellularly [125].